{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:30Z","timestamp":1786994010665,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024514","name":"Stem Cell Research Center, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["65108"],"award-info":[{"award-number":["65108"]}],"id":[{"id":"10.13039\/501100024514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.mcp.2024.101969","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T19:43:29Z","timestamp":1720122209000},"page":"101969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The effectiveness of ruxolitinib and cyclophosphamide combination on T helper 17 and regulatory T cells in rat experimental membranous glomerulonephritis"],"prefix":"10.1016","volume":"76","author":[{"given":"Rahim","family":"Iranzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadbagher","family":"Pirouzpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Biglari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Khaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Roshangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Badihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshid","family":"Afandideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reihane","family":"Shahabirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Shekarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Ahmadian Heris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9823-5454","authenticated-orcid":false,"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mcp.2024.101969_bib1","first-page":"4197","article-title":"Network analysis of membranous glomerulonephritis based on metabolomics data","volume":"18","author":"Taherkhani","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.mcp.2024.101969_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.ekir.2019.07.021","article-title":"Membranous glomerulonephritis with crescents","volume":"4","author":"Nikolopoulou","year":"2019","journal-title":"Kidney International Reports"},{"issue":"1","key":"10.1016\/j.mcp.2024.101969_bib3","first-page":"41","article-title":"Membranous glomerulonephritis\u2013gender-related differences of disease course and evaluation of therapy efficiency","volume":"21","author":"Guerguinova","year":"2019","journal-title":"\u041d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0434\u0438\u0430\u043b\u0438\u0437"},{"issue":"7","key":"10.1016\/j.mcp.2024.101969_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2215\/CJN.11001210","article-title":"Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy","volume":"6","author":"Cattran","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mcp.2024.101969_bib5","doi-asserted-by":"crossref","unstructured":"M. Scorer, O. Golberg, K. Harman, Cyclophosphamide, Handbook of Systemic Drug Treatment in Dermatology, CRC Press2023, pp. 112-119.","DOI":"10.1201\/9781003016786-16"},{"key":"10.1016\/j.mcp.2024.101969_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127704","article-title":"Immunomodulation\u2014a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system","volume":"14","author":"Strzelec","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mcp.2024.101969_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/injr.injr_28_19","article-title":"Safety of cyclophosphamide therapy in autoimmune rheumatic diseases","volume":"14","author":"Subramanian","year":"2019","journal-title":"Indian J. Rheumatol."},{"key":"10.1016\/j.mcp.2024.101969_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.intimp.2016.01.008","article-title":"Zhen-Wu-tang attenuates cationic bovine serum albumin-induced inflammatory response in membranous glomerulonephritis rat through inhibiting AGEs\/RAGE\/NF-\u03baB pathway activation","volume":"33","author":"Wu","year":"2016","journal-title":"Int. Immunopharm."},{"issue":"10","key":"10.1016\/j.mcp.2024.101969_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneph.2017.112","article-title":"T helper type 17 cells in immune-mediated glomerular disease","volume":"13","author":"Krebs","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.mcp.2024.101969_bib10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","article-title":"Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney","volume":"45","author":"Krebs","year":"2016","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.mcp.2024.101969_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.mcp.2024.101969_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.mcp.2024.101969_bib13","doi-asserted-by":"crossref","first-page":"20935","DOI":"10.1002\/jcp.28698","article-title":"Cytokine profile, Treg\/Th17 cell frequency changes during different posttransplantational time points in patients undergoing renal transplantation","volume":"234","author":"Mortazavi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.mcp.2024.101969_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.mcp.2024.101969_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.mcp.2024.101969_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.mcp.2024.101969_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1681\/ASN.2012070684","article-title":"Regulatory T cell\u2013derived IL-10 ameliorates crescentic GN","volume":"24","author":"Ostmann","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mcp.2024.101969_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155452","article-title":"Altered Th17\/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy","volume":"141","author":"Motavalli","year":"2021","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.mcp.2024.101969_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ki.2010.158","article-title":"JAK\/STAT signaling in renal diseases","volume":"78","author":"Chuang","year":"2010","journal-title":"Kidney Int."},{"issue":"19","key":"10.1016\/j.mcp.2024.101969_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911788","article-title":"Why do we need JAK inhibitors in systemic lupus erythematosus?","volume":"23","author":"Richter","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mcp.2024.101969_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-023-01225-7","article-title":"Pharmacokinetics and pharmacodynamics of ruxolitinib: a review","volume":"62","author":"Appeldoorn","year":"2023","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.mcp.2024.101969_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41577-023-00877-7","article-title":"Protein kinases: drug targets for immunological disorders","volume":"23","author":"Castelo-Soccio","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcp.2024.101969_bib23","article-title":"Janus kinase inhibitors in autoimmune bullous diseases","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.mcp.2024.101969_bib24","first-page":"1626","article-title":"Alleviating the storm: ruxolitinib in HLH","volume":"127","author":"La Ros\u00e9e","year":"2016","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.mcp.2024.101969_bib25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3389\/fonc.2019.01186","article-title":"Mechanisms underlying the anti-inflammatory and immunosuppressive activity of ruxolitinib","volume":"9","author":"Elli","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.mcp.2024.101969_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/ph15030374","article-title":"New applications of JAK\/STAT inhibitors in pediatrics: current use of ruxolitinib","volume":"15","author":"Marcuzzi","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.mcp.2024.101969_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269085","article-title":"Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model","volume":"17","author":"Coyne","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.mcp.2024.101969_bib28","article-title":"Sanqi oral solution mitigates proteinuria in rat passive heymann nephritis and blocks podocyte apoptosis via Nrf2\/HO-1 pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.mcp.2024.101969_bib29","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.3324\/haematol.2019.222471","article-title":"Ruxolitinib for refractory\/relapsed hemophagocytic lymphohistiocytosis","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.mcp.2024.101969_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cei.12729","article-title":"Immunology of membranous nephropathy: from animal models to humans","volume":"183","author":"Sinico","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.mcp.2024.101969_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","article-title":"The role of complement in kidney disease","volume":"19","author":"Petr","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.mcp.2024.101969_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-022-04737-5","article-title":"Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.mcp.2024.101969_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000166481","article-title":"Membranous nephropathy: response to steroids and immunosuppression","volume":"1","author":"Suki","year":"1981","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.mcp.2024.101969_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000506758","article-title":"A prospective pilot study of graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and ruxolitinib in patients with myelofibrosis","volume":"144","author":"Morozova","year":"2021","journal-title":"Acta Haematol."},{"key":"10.1016\/j.mcp.2024.101969_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.mcp.2024.101969_bib36","first-page":"487","article-title":"Animal experiments on the anti-inflammatory and immunosuppressive effect of cytostatic agents","volume":"23","author":"M\u00fcller","year":"1973","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.mcp.2024.101969_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00262-012-1322-5","article-title":"Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine","volume":"62","author":"Peng","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"issue":"21","key":"10.1016\/j.mcp.2024.101969_bib38","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1182\/blood.V122.21.4092.4092","article-title":"JAK inhibition reduces CD25 high CD27+ FOXp3+ T regulatory cells and causes a silencing of T effector cells in patients with myeloproliferative neoplasms whilst promoting a TH17 phenotype","volume":"122","author":"Keohane","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mcp.2024.101969_bib39","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1158\/0008-5472.CAN-10-0283","article-title":"Selective depletion of CD4+ CD25+ Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.mcp.2024.101969_bib40","first-page":"3905","article-title":"Tumor indoleamine 2, 3-dioxygenase (Ido) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs","volume":"125","author":"Ninomiya","year":"2015","journal-title":"Blood, The Journal of the American Society of Hematology"}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850824000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850824000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T05:18:52Z","timestamp":1721193532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850824000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"alternative-id":["S0890850824000215"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2024.101969","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of ruxolitinib and cyclophosphamide combination on T helper 17 and regulatory T cells in rat experimental membranous glomerulonephritis","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2024.101969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101969"}}